The financials
Neogen Corporation by the numbers
Neogen Corporation (NEOG) reported revenue of $211M in Q3 2026 (quarter ended Feb 28, 2026), down 4.4% from the same quarter a year earlier. That came with a gross margin of 47% and net loss of $17M. For the full year FY2025, revenue was $895M (−3.2% year on year) and net income −$1.09B. Its largest product in Jun 2026 was Bacterial And General Sanitation at $47M, 40% of the disclosed total, ahead of Service at 23%.
| Income statement | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $211M | $221M | −4.4% |
| Gross profit | $99M | $110M | −10% |
| Operating income | −$3.3M | $5.4M | to a loss |
| Net income | −$17M | −$11M | n/a |
| Diluted EPS | −$0.08 | −$0.05 | n/a |
| Product | Revenue | Share |
|---|---|---|
| Bacterial And General Sanitation | $47M | 40% |
| Service | $26M | 23% |
| Natural Toxins And Allergens | $19M | 16% |
| Veterinary Instruments And Disposables | $16M | 14% |
| Genomics Services | $6.6M | 5.6% |
| Life Sciences | $1.8M | 1.5% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $116.6M (-43%)
Bacterial And General Sanitation grew +10% year on yearVeterinary Instruments And Disposables -2.4% year on year
Segment Latestquarter on quarteryear on year
- Bacterial And General Sanitation$46.7M$46.7MQoQ +11%year on year +10%+11%+10%
- Service$26.5M$26.5MQoQ +5.9%year on year +7.4%+5.9%+7.4%
- Natural Toxins And Allergens$19.2M$19.2MQoQ +7.3%year on year +3.7%+7.3%+3.7%
- Veterinary Instruments And Disposables$15.8M$15.8MQoQ +2.0%year on year -2.4%+2.0%-2.4%
- Genomics Services$6.6M$6.6MQoQ +6.2%year on year +4.5%+6.2%+4.5%
- Life Sciences$1.8M$1.8MQoQ +20%year on year +9.3%+20%+9.3%